
Billy Evans, accomplice of Theranos founder Elizabeth Holmes, is engaged on a brand new startup that seeks to ship “human well being optimization” by way of blood testing, according to The New York Times.
The Occasions reportedly spoke to 2 buyers pitched on the startup, known as Haemanthus, and likewise considered a few of Haemanthus’ advertising supplies.
In these supplies, the corporate says it has developed a machine that makes use of lasers to investigate blood, saliva, and urine samples to detect most cancers and infections. It reportedly plans to begin with pet well being earlier than increasing to people, and it seeks to boost greater than $50 million.
The pitch echoes that for Theranos, which promised to conduct a wide range of medical exams on tiny quantities of blood drawn from pricked fingers. In 2022, Holmes (with whom Evans has two kids) was sentenced to 11 years in prison for defrauding buyers, although she said in a recent interview that she stays “utterly dedicated to my dream of constructing reasonably priced healthcare options accessible to everybody.”
Early Fb investor Jim Breyer instructed The Occasions that his staff was requested to take a position however declined “for lots of the similar causes we handed twice on Theranos.”
Trending Merchandise

